Results 221 to 230 of about 11,219 (248)

Development of Generalized Myasthenia Gravis in Patients With Ocular Myasthenia Gravis—Reply

Archives of Neurology, 2003
Peter Homel, Mark J. Kupersmith
openaire   +1 more source

Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis

Expert Opinion on Investigational Drugs, 2021
James F Howard, John Vissing, Nils Erik Gilhus   +2 more
exaly  

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

JAMA Neurology, 2022
Fredrik Piehl, Daniel Jons, Ivan Kmezić   +2 more
exaly  

Myasthenia gravis: general features

2021
openaire   +1 more source

Thymectomy in thymomatous generalized myasthenia gravis: An analysis of the prognosis and risk factors

European Journal of Neurology, 2023
Jinwei Zhang, Yuantao Cui, Peng Zhang
exaly  

Real-world utilization patterns of intravenous immunoglobulin in adults with generalized myasthenia gravis in the United States

Journal of the Neurological Sciences, 2022
Yuebing Li
exaly  

Generalized trichoepitheliomas with alopecia and myasthenia gravis

Journal of the American Academy of Dermatology, 1988
S. Miyakawa, Y. Araki, M. Sugawara
openaire   +1 more source

Seronegative autoimmune generalized Myasthenia Gravis

Journal of Autoimmunity, 1989
C. Casali, S. D'Agostini, I. La Cesa, A. Peppe, C. Scoppetta   +4 more
openaire   +1 more source

Risk of Ocular Myasthenia Gravis Transitioning to Generalized Myasthenia Gravis

Qing Zhou, Jian Chen
openaire   +1 more source

Thymectomy in Children with Generalized Myasthenia Gravis

Neuropediatrics, 1997
G. Ramelli, M. Sturzenegger, M. Bianchetti, F. Vassella   +3 more
openaire   +1 more source